Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1283-1288, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1283-1288.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Serum Immunoglobulin G Immune Response to Helicobacter
pylori Antigens in Mongolian Gerbils
Toshiko
Kumagai,1
Jing
Yan,2
David Y.
Graham,3,4
Minoru
Tozuka,1
Yukie
Okimura,1
Tatsuo
Ikeno,5
Atsushi
Sugiyama,5
Tsutomu
Katsuyama,1,2 and
Hiroyoshi
Ota1,6,*
Central Clinical
Laboratories1 and Department of
Endoscopy,6 Shinshu University Hospital, and
Department of Laboratory Medicine2 and
First Department of Surgery,5 Shinshu
University School of Medicine, Nagano 390-8621, Japan, and
Departments of Medicine3 and
Molecular Virology and
Microbiology,4 Veterans Affairs Medical Center
and Baylor College of Medicine, Houston, Texas 77030
Received 31 July 2000/Returned for modification 21 October
2000/Accepted 11 January 2001
 |
ABSTRACT |
The Mongolian gerbil model for Helicobacter pylori
infection is an animal model that mimics human disease. We examined the serum immune response to H. pylori infection in gerbils by
enzyme-linked immunosorbent assay (ELISA) and Western blotting, both
with whole-cell (H. pylori) extracts. A total of 66 7-week-old specific-pathogen-free male gerbils were inoculated
orogastrically with H. pylori strain ATCC 43504. Sera were
collected 1, 2, 4, 8, 12, 26, 38, and 52 weeks after H. pylori inoculation. Sixty-nine noninfected gerbils and their sera
were used as controls. The specificity of the ELISA was 95.7%. The
frequency of seropositivity increased over time: 2 of 10 (20%), 7 of
10 (70%), and 7 of 7 (100%) samples of sera from inoculated gerbils
were positive for H. pylori at 2, 4, and 8 weeks
postinoculation, respectively. Western blot assays showed that the
primary immunoglobulin G (IgG) response against low-molecular-mass (25-, 30-, and 20-kDa) proteins appeared after a lag period of 2 to 8 weeks after inoculation. Antibodies against 160-, 150-, 110-, 120-, 80-, 66-, and 63-kDa proteins were observed 12 weeks after
inoculation. The early reactive 30-kDa protein was identified as a
urease
subunit by N-terminal amino acid sequencing. After 26 weeks,
two groups of animals could be distinguished: one group developed
ulcers (n = 5), and the other developed hyperplastic polyps without ulcers (n = 19). Gerbils in the gastric
ulcer group showed significantly higher serum anti-H.
pylori IgG levels than did gerbils in the hyperplastic group
(P = 0.001) as measured by ELISA. Furthermore, a
higher proportion of animals developed antibodies to H. pylori proteins of 26, 25, and 20 kDa in the ulcer group than
those animals with hyperplastic polyps (75 to 100% versus 17 to 50%)
in Western blot assays. These results highlight the importance of the
immune response of the host in the development of H. pylori-related gastric lesions.
 |
INTRODUCTION |
Helicobacter pylori is
the most important etiological agent of chronic active gastritis and
peptic ulcer disease. H. pylori infection is also
epidemiologically related to gastric carcinoma, and it has been
classified as a group 1 carcinogen by the International Agency for
Research on Cancer (21). Although all H. pylori-infected subjects have gastritis, in most cases the
infection remains latent, with only a minority developing a symptomatic
clinical disease such as peptic ulcer disease, gastric lymphoma, or
adenocarcinoma. The risk factors for development of clinical diseases
remain poorly understood.
A well-characterized animal model that mimics human
H. pylori infection would significantly enhance
the investigation of histopathogenic features of the interaction
between the bacterium and the host's gastric mucosa. Hirayama et al.
(17, 18) succeeded in establishing a Mongolian gerbil
model that mimics human H. pylori infection. Ikeno et al.
(20) reported the histological and histochemical characteristics of the gastric mucosa of normal and H. pylori-infected gerbils. H. pylori-infected gerbils
developed gastritis, intestinal metaplasia, and gastric ulcers by 1 year after the experimental infection. More recently, Sugiyama et al.
(30), Watanabe et al. (38), and Honda et al.
(19) have shown that gastric carcinoma may also develop in
H. pylori-infected Mongolian gerbils.
Understanding the serum immune response in this model might provide
clues to the different outcomes of H. pylori infection. However, neither methods to measure serum anti-H.
pylori antibody levels nor the time-dependent pattern of the serum
antibody response to H. pylori in gerbils has been well
described. The study reported here was undertaken with two aims: (i) to
develop an enzyme-linked immunosorbent assay (ELISA) method to measure
anti-H. pylori immunoglobulin G (IgG) levels in sera from
H. pylori-infected gerbils and (ii) to identify the
time-dependent antibody patterns in H. pylori-infected gerbils by using ELISA and Western blot assays.
 |
MATERIALS AND METHODS |
Preparation of horseradish peroxidase-conjugated anti-gerbil
antibody.
Normal gerbil IgG was purified by protein A column
chromatography (Seikagaku Kogyo, Tokyo, Japan), using the method of Ey et al. (14). New Zealand White rabbits were immunized
subcutaneously several times with purified gerbil IgG containing
complete Freund's adjuvant (Kanto Chemicals, Tokyo, Japan). Titers of
immune sera were determined by the methods of Ouchterlony
(29). A Fab' fragment of rabbit anti-gerbil IgG conjugated
to horseradish peroxidase (HRP) was prepared by the method of Ishikawa
et al. (22). Briefly, the IgG fraction of immunized New
Zealand White rabbit sera was separated by protein-A column
chromatography. The IgG was digested by pepsin in 0.1 M acetate buffer
(pH 4.5) at 37°C for 18 h, and the F(ab')2 fragment
was isolated by gel filtration (Ultrogel AcA-44; Pharmacia Biotech AB,
Uppsala, Sweden). The Fab' fragment was prepared by reducing the
F(ab')2 fragment by 0.01 M 2-mercaptoethyamine (pH 6.0) at
37°C for 90 min, followed by gel filtration (Sephadex G-25; Pharmacia
Biotech AB). Fab' fragments were mixed with
N-succinimidyl-6-maleimidohexanoate-HRP complex (30°C, 60 min), and then the HRP-Fab' fragments were purified by gel filtration
on Ultrogel AcA-44. The conjugated material was dialyzed against
phosphate-buffered saline (PBS) (pH 7.4) and then concentrated.
Animals.
Specific-pathogen-free 7-week-old male gerbils
(MGS/Sea; Seac Yoshitomi, Fukuoka, Japan) were housed in an
air-conditioned biohazard room for infection, with a 12-hour-light and
12-hour-dark cycle. They were given food (CE-2; Clea Japan, Inc.,
Tokyo, Japan) and water ad libitum.
Bacterial strain and inoculation.
H. pylori
strain ATCC 43504 (American Type Culture Collection, Manassas, Va.) was
grown in brucella broth (Becton Dickinson, Cockeysville, Md.)
supplemented with 10% (vol/vol) horse serum and agitated at 35°C for
40 h in saturated humidity in the presence of 15%
CO2. After a 24-h period of fasting, each animal was
inoculated with a 0.5-ml inoculum of 109 CFU of H. pylori per ml intragastrically, using a feeding needle. Four hours
after administration, animals were again allowed free access to water
and food. H. pylori strain ATCC 43504 is CagA positive
and produces VacA vacuolating cytotoxin.
Serum samples from Mongolian gerbils.
Before animals were
sacrificed, blood samples were obtained from the orbital plexus using
hematocrit tubes. Sera were obtained from 66 H. pylori-infected gerbils and 69 noninfected gerbils. That is, 5, 10, 10, 7, 10, 5, 4, and 15 serum samples were obtained at 1, 2, 4, 8, 12, 26, 38, and 52 weeks, respectively, after H. pylori
inoculation. In addition, 11, 18, 18, 4, 11, 5, and 2 sera were
obtained from gerbils in the noninfected group at ages 7, 10, 11, 15, 19, 33, and 59 weeks, respectively. Immediately after collection of the
blood, gerbils were killed by cervical dislocation, and their stomachs
were collected for microbiological and histological studies. The
success of the experimental infection at each point was determined by
the presence of positive results of culture and/or immunohistological staining.
ELISA.
Anti-H. pylori IgG values in sera from
gerbils were determined by ELISA. The reference serum, which was pooled
from sera of anti-H. pylori IgG-positive gerbils, was
diluted serially from 1:100 to 1:3,200 with PBS (pH 7.4) containing 4%
bovine serum albumin, and the amount of anti-H. pylori IgG
corresponding to a 1:3,200 dilution was expressed as a reference value
of a 1.0 arbitrary index (AI). Microwell strips coated with H. pylori antigens from a GAP-IgG kit (Biomerica, Newport Beach,
Calif.) were used. The antigens in the GAP-IgG kit were acid extracts
of organisms derived from the H. pylori ATCC 43504 strain.
Aliquots of 100 µl of reference serum or 1:200 of diluted serum were
added to the wells, and the plates were incubated for 1 h at room
temperature. After washing was done, 100 µl of HRP-conjugated
anti-gerbil IgG (diluted 1:1,500 in PBS containing 0.05% Tween 20 [PBS-T]) was added, and the plates were incubated for 30 min at room
temperature. The plates were washed and incubated with 100 µl of
substrate (0.35 mg of 3,3',5,5'-tetramethylbenzidine per ml and 0.15 mg of H2O2 per ml) for 10 min. After stopping the
reaction with 1 N HCl, the color was read at 450 nm. The serum
anti-H. pylori IgG value was determined from a standard
curve of calibrators (21, 23, 24, 30).
Antigen for Western blotting.
H. pylori cells of
strain ATCC 43504 were harvested by centrifugation at 1,300 × g for 10 min at 4°C. The cells were suspended in washing
buffer (1.0 M NaCl, 100 mM EGTA, 10 mM Tris-HCl [pH 8.0]) and washed
twice with the same buffer. The washed cells were suspended in PBS (pH
7.4) and disrupted by sonication on ice by using a sonifier (Sonifier
250 D; Branson, Danbury, Conn.). The cell solubilisate was centrifuged
at 12,000 × g for 20 min at 4°C, and the supernatant
was dialyzed against PBS (pH 7.4) for 48 h. The suspension was
stored at
80°C until used.
Western blotting.
The sonicated cell extract was separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
in 8 to 16% polyacrylamide gels and transferred electrophoretically to
nitrocellulose membranes (Toyo Roshi, Tokyo, Japan) at 0.8 mA/cm2 for 1 h at room temperature (Pharmacia LKB
Biotechnology, Uppsala, Sweden). The blots were soaked in blocking
solution (2% nonfat milk and 0.1% Tween 20 in PBS) for 1 h and
then incubated for 1 h at room temperature with gerbil serum
(1:100 to 1:4,000 diluted with blocking solution). After washing three
times in PBS-T, the membranes were incubated for 1 h at room
temperature with HRP-conjugated anti-gerbil IgG diluted 1:500 in
blocking solution. After the washings in PBS-T, enhanced
chemiluminescence (ECL) reagents (Amersham, Buckinghamshire, England)
were used for detection of the Western blotting assay products. The
ECL-detected blots were exposed to autoradiography film (Hyperfilm ECL;
Amersham), and the film was developed using an X-ray film developer
(Rendol; Fujifilm, Tokyo, Japan).
Two-dimensional gel electrophoresis.
Two-dimensional gel
electrophoresis (GE) combining isoelectric focusing (IEF) in the first
dimension and SDS-PAGE in the second dimension was performed. H. pylori ATCC 43504 (1010 cells) was solubilized in 5 ml
of solubilization solution {8 M urea, 4% [wt/vol]
3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate, 100 mM dithiothreitol, 40 mM Tris-base, and 0.5% [vol/vol]
Ampholine [pH 3.5 to 10; Pharmacia Biotech AB] [pH 9.5]},
vortexed, sonicated, and centrifuged at 12,000 × g for
20 min at 4°C. Following centrifugation, the supernatant was focused
on 4% polyacrylamide gel containing 5% Ampholine (pH 3.5 to 10)-8 M
urea-10% glycerol-0.06% ammonium persulfate-0.08%
N,N,N',N'-tetramethyl-ethylenediamine. IEF was performed
under a constant current of 200 V for 16 h. A slice gel of IEF was
then separated by SDS-PAGE (8 to 16% gel), blotting to polyvinylidene
difluoride (PVDF) or nitrocellulose membrane, staining, and imaging as
described above.
N-terminal amino acid sequences.
Coomassie blue-stained
protein excised from a PVDF membrane was Edman sequenced for amino acid
residues to provide an N-terminal amino acid sequence using a Procise
494 cLC (Applied Biosystems, Foster City, Calif.)
Statistical analysis.
Student's t test and
Fisher's exact test were used to assess the significance of
differences between means at each time point. The differences were
considered to be significant when P was <0.05.
 |
RESULTS |
Macroscopic changes in H. pylori-inoculated
gerbils.
Details of the histological changes in the gastric mucosa
of H. pylori-inoculated gerbils have been described
previously (20). Briefly described, time-dependent changes
occurred throughout the gastric mucosa of all H. pylori-inoculated gerbils. There were no visible changes in the
gastric mucosa of any noninfected gerbils or gerbils at 2 weeks
postinfection. At 4 weeks after infection, the antral mucosa appeared
slightly expanded and thickened and was covered by abundant mucus.
Visible gastritis with edema and bleeding appeared at 12 weeks after
inoculation. From week 26 through 52 postinoculation, two groups of
animals could be distinguished; in one group the stomach showed ulcers,
located distally close to the transitional zone between fundic and
pyloric mucosa (ulcer group), and the other group showed many sessile hyperplastic polyps with occasional apical erosions but no ulcers (hyperplastic group). At 26, 38, and 52 weeks postinoculation, respectively, 2 of 5, 1 of 4, and 2 of 15 gerbils exhibited peptic ulcer.
Bacteriology.
Culturing of a piece of gastric mucosa (1 mm)
obtained from the posterior wall of the antrum was done in samples from
60 of 66 experimentally H. pylori-inoculated gerbils.
Culture examination showed no detectable H. pylori at 2 weeks postinoculation. H. pylori were cultured from the
samples from 25 of 27 gerbils (93%) at 12 weeks and from the samples
from 5 of 5 gerbils (100%) of the ulcer group and 4 of 13 gerbils
(31%) of the hyperplastic group at 52 weeks. All gerbils in the ulcer
group and in the hyperplastic group were H. pylori positive
by histology, and the infection persisted up to the end of the
experiment at 52 weeks.
Precision of ELISA.
The same day reproducibility was
determined by making eight replicate measurements of three kinds of
control sera on the same plate. Each control serum showed a mean of
0.65, 5.38, and 18.13 AI, and a coefficient of variation of 10.4, 6.7, and 6.4%, respectively. The between-day reproducibility was determined
by making duplicate measurements of three kinds of control sera on each
of 5 consecutive days. The control sera showed a mean of 0.23, 4.73, and 9.43 AI, and a coefficient of variation of 10.9, 9.4, and 9.5%,
respectively. The detection limit of ELISA was 0.2 AI when it was
defined as 2 standard deviations (SDs) above zero.
Cut-off values of anti-H. pylori IgG antibodies.
A
total of 69 serum samples from noninfected gerbils aged 7 to 59 weeks
showed a mean of 0.78 AI with an SD of 0.38 AI. The titer increased
slightly with age (P < 0.001) such that the cutoff value of serum anti-H. pylori IgG antibodies for gerbils
15 weeks of age was defined as 1.37 AI and for gerbils >15 weeks of
age was defined as 1.90 AI, based on the mean plus 2 SD. No noninfected gerbils showed positive serum results from culture or
immunohistological staining. Sixty-six of 69 noninfected gerbils
(95.7%) showed negative values, while three showed false-positive
values; that is, specificity of this ELISA was 95.7%.
Change of serum anti-H. pylori IgG antibodies after
inoculation.
A total of 66 serum samples of gerbils were obtained
at 1, 2, 4, 8, 12, 26, 38, and 52 weeks after H. pylori
inoculation. The primary IgG response appeared after a lag period of 2 to 8 weeks after inoculation. The changes in serum anti-H.
pylori IgG antibodies detected by ELISA in infected groups are
shown in Fig. 1. Sera from none of 5 (0%), 2 of 10 (20%), 7 of 10 (70%), and 7 of 7 (100%) gerbils
showed positive anti-H. pylori IgG antibody levels
at 1, 2, 4, and 8 weeks postinoculation, respectively. At 8 weeks
after inoculation or later, 100% of gerbils had positive anti-H.
pylori IgG levels.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
The change over 52 weeks in serum levels of
anti-H. pylori IgG in gerbils after H. pylori
inoculation. IgG levels were determined by ELISA. , serum antibody
level of gerbils during first 12 weeks after inoculation. Mean antibody
values (n = 5, 10, 10, 7, and 10) were 0.9, 0.9, 2.4, 21.5, and 31.9 AI, respectively. , serum antibody level of ulcer
group. Mean value and SD of the group were 605.1 and 159.4 AI
(n = 2, 1, and 2) at 26, 38, and 52 weeks
postinoculation, respectively. , serum antibody level of
hyperplastic group. Mean value and SD of the group were 177.4 and 120.8 AI (n = 3, 3, and 13) at 26, 38, and 52 weeks
postinoculation, respectively. For other details, see Results.
|
|
After 52 weeks, 5 of 24 gerbils exhibited gastric ulcers, and the
others had gastric hyperplasia. The mean serum anti-H.
pylori IgG value (±SD) of gerbils in the ulcer group was
605.1 ± 159.4 AI. The mean value for gerbils in the hyperplastic
group was 177.4 ± 120.8 AI. The values in the ulcer group were
significantly higher than those of the hyperplastic group (P = 0.001).
Western blotting.
The major proteins of whole-cell sonicates
were 160, 150, 120, 110, 80, 66, 63, 49, 35, 30, and 26 kDa in apparent
molecular mass (Fig. 2A, lane 1). The
first detectable IgG antibody of gerbils to H. pylori was
observed against 25-kDa proteins and the earliest response in a gerbil
was seen 2 weeks after inoculation (Fig. 2B, lane 4). This was followed
by development of additional IgG antibody against a 30-kDa protein(s),
then by antibody against a 20-kDa protein(s) (lanes 5 and 6). The
reactive band against 49-kDa proteins was observed in both noninfected
gerbils and H. pylori-infected gerbils (lanes 2 to 9) and
was considered nonspecific. Additional antibodies against 160-kDa and
63-kDa proteins were followed by the appearance of antibodies against
150-, 120-, 110-, 80-, and 66-kDa proteins, which were observed 12 weeks after inoculation (lanes 7 to 9). At 26 weeks or later, the
pattern of response differed between animals in the ulcer group (lanes
10, 12, and 14) and those in the hyperplastic group (lanes 11, 13, and
15). The antibodies against 25-, 26-, and 20-kDa proteins tended to be
more frequent, and antibody bands against 120- and 110-kDa proteins
tended to be both clear and strong in sera from the ulcer group
compared to sera from those in the hyperplastic group.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Lane 1, protein profile of whole-cell sonicates of
H. pylori ATCC 43504. Proteins were separated on an
SDS-8 to 16% PAGE gradient gel and stained with Coomassie brilliant
blue R-250. (B) The time course of Western blotting patterns with sera
from H. pylori-inoculated gerbils. Lane 2, serum from a
noninoculated gerbil; lanes 3 to 15, sera from inoculated gerbils.
Times after inoculation were as follows: lanes 3 and 4, 2 weeks; lanes
5 and 6, 4 weeks; lanes 7 and 8, 8 weeks; lane 9, 12 weeks; lanes 10 and 11, 26 weeks; lanes 12 and 13, 38 weeks; lanes 14 and 15, 52 weeks.
Lanes 10, 12, and 14 show sera from the ulcer group; lanes 11, 13, and
15 show sera from the hyperplastic group. Sera were diluted as follows:
lanes 2 to 6, 1:100; lanes 7 to 9, 1:1,000; lanes 10 to 15, 1:4,000.
Molecular masses are indicated in kilodaltons.
|
|
We compared the frequency of the presence of immunoreactive bands among
eight bands (160-, 150-, 120-, 110-, 30-, 26-, 25-, and 20-kDa
proteins) between sera from gerbils of the ulcer group and the
hyperplastic group (Table 1). The
presence of a band at 26 and 25 kDa in the ulcer group tended to be
more frequent than in the hyperplastic group, but the small sample size
precluded determination of a significant relationship.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Frequencies of eight antibodies to H. pylori
in sera from 16 Mongolian gerbils of ulcer group and hyperplastic group
|
|
Characterization of the early reactive proteins.
To determine
the nature of the early reactive proteins, the cell extract was
separated by two-dimensional GE, transferred to PVDF membrane, and then
stained with Coomassie blue (Fig. 3A) or
assayed by Western blotting with serum samples from gerbils taken at 5 weeks postinoculation (Fig. 3B). The isoelectric point (pI) of early
reactive protein of 25 kDa was approximately 8.6 to 8.8 (Fig. 3B,
asterisk). The horizontal streaking was observed against 20- and 30-kDa
proteins (Fig 3B, arrow and arrowhead, respectively). The
Coomassie-stained spots of 30-kDa (pI = 8.6 to 8.8) protein were
in agreement on Western blotting spots (arrow). The N-terminal amino
acid sequence of 30-kDa protein (pI = 8.6 to 8.8) revealed that
the first eight amino acid sequences were MKLTPKEL. The
sequence of the protein was identified as a urease
subunit of
H. pylori by a search of the SWISS-PROT database (http://www.ebi.ac.uk/swissprot/).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Protein spots of whole-cell sonicate of H. pylori ATCC 43504. Proteins were separated by two-dimensional GE:
isoelectric focusing in the first dimension and SDS-PAGE in the second
dimension. Proteins were transferred to PVDF membrane and then stained
with Coomassie brilliant blue R-250. (B) Western blot result of the
same preparation with serum from a gerbil taken 5 weeks after H. pylori inoculation. Serum was diluted 1:100. The pH is indicated
at the top of the figure and molecular masses in kilodaltons are
indicated on the right-hand side. Arrow, asterisk, and arrowhead
indicate 30-, 25-, and 20-kDa proteins, respectively.
|
|
 |
DISCUSSION |
The time- and antigen-dependent immune response to
H. pylori has not yet been described in humans, in part
because the time of acquisition of the infection can not be identified
in most individuals. We established an ELISA and Western blotting
system for detecting serum immune response to H. pylori in
gerbils and to study the time- and antigen-dependent immune response to
H. pylori infection. We used the gerbil model, which
mimics human H. pylori infection (17, 18, 20,
30), and newly prepared HRP-conjugated anti-gerbil IgG antibody
to analyze the serum immune responses from the time of inoculation of
H. pylori for periods up to 1 year after inoculation.
Western blotting allows for the analysis of the immune response to a
number of defined antigens. Moreover, ECL Western blotting is a highly
sensitive system (39) with at least 10-fold greater sensitivity than other nonradioactive or radioactive
Western blotting systems (1). In this study, we found that
the primary IgG antibody response was against low-molecular-mass
proteins (25-, 30-, and 20-kDa proteins, in that order) and appeared
after a lag period of 2 to 8 weeks. The lag period corresponded to the
cellular events in the activation, proliferation, and differentiation
of B cells to antibody-secreting cells (5). Vos et al.
(36) reported humoral immune response to a
thymus-independent (Escherichia coli lipopolysaccharide) and
thymus-dependent (tetanus toxoid) antigen in 8-week-old male rats
immunized intravenously. The IgG antibody response pattern of our study
was similar to that of the response pattern to thymus-dependent
antigen, but the lag period observed by Vos et al. was shorter (i.e., 5 to 20 days). One of the reasons for the difference in lag period may be
the difference in immune pathway (i.e., mucosal immunity versus
parenteral immunity). Takahashi et al. (32) reported an
oral immune response when mice were administrated tetanus toxoid orally
with E. coli heat-labile toxin as an adjuvant. Tetanus
toxoid-specific IgG1 and IgG2b responses appeared by day 7, and peak
titers were seen by day 14. On the other hand, IgG2a appeared by day 14 and gradually increased throughout the intervals assessed. Our study
does not provide information regarding the specific antibodies against
the IgG subclass of gerbils. There may be substantial differences in
host immune responses. H. pylori is a mucosal pathogen that
has the ability to colonize in host tissue, while tetanus toxoid does
not. Further studies on the immune system of H. pylori
infection are needed.
The first reactive antigens in the range of the 25-, 30-, and 20-kDa
proteins in this study stimulated interest in the colonization of the
bacterium and the host immune system. Binding and adhesion of the
bacterium to the gastric mucosa are thought to be an important first
step in bacterial colonization. A 30-kDa protein was identified as
a urease
subunit of H. pylori. The horizontal
streaking of this protein observed in Fig. 3B appears to be a result of
incomplete focusing, which may indicate that the protein has become
insoluble during the IEF run (16). Our data are similar to
those of Dunn et al. (8), who reported that this urease
subunit was not resolved by two-dimensional GE. H. pylori
urease is a cell-bound enzyme and is composed of two protein subunits,
with molecular masses of 66 kDa (pI = 5.93) and 30 kDa
(12). Our results suggested that the urease
subunit
may be involved early in colonization and in the host immune response.
The amount of the 25-kDa protein (pI = 8.6 to 8.8) was too little
to determine N-terminal amino acid sequences. The amount of a 20-kDa
protein was also insufficient for N-terminal amino acid sequencing, and
it was not well resolved by two-dimensional GE because there was also
considerable horizontal streaking at the 20-kDa protein on the
second-dimension gel. Sugiyama et al. (31) reported a
unique antibody against 25-kDa antigen in sera from patients of chronic
gastritis and gastric ulcer associated with H. pylori.
Valkonen et al. (34) also reported 25-kDa outer membrane
protein of H. pylori as
N-acetylneuraminyllactose-specific laminin-binding protein.
Evans et al. reported 20-kDa HpaA as an adhesin subunit (10,
11), and an immunoreactive species-specific 19-kDa outer
membrane protein was reported by Drouet et al. (7), but it
is as yet uncharacterized. Approximately 29- to 31-kDa urease subunit
proteins, surface and outer membrane proteins of H. pylori
such as 31- or 30-kDa proteins, and various reactive antigens of
water-soluble proteins have been reported (3, 4, 6, 9, 12, 13,
15, 26). Results in different studies may depend on the methods
of growing the bacteria and preparing the antigens and the details of
the ELISA or Western blot. Data from humans suffer from this
variability, and it is not possible to directly correlate the results
between gerbils and humans. Some but not all of our results are in
agreement with previous work with humans (2, 7, 25, 27).
Mitchell et al. (25) reported that the presence of a band
at 116, 89, and 35 kDa or of any two bands at 30, 26.5, and 19.5 kDa
was a marker of H. pylori infection in humans. Nilsson et
al. (27) reported that bands of 110 or 120 kDa and/or two
of five low-molecular-mass proteins (26, 29, 30, 31, and 33 kDa) showed
a strong correlation with H. pylori-positive patients. Evans
et al. (13) reported a 150-kDa (15-kDa subunit)
water-soluble antigen as a neutrophil-activating protein. Common
reactive bands from low-molecular-mass proteins (about 20, 25 to 26, and 30 kDa) and from high-molecular-mass proteins (about 110 or 120 and
150 kDa) were found in both gerbils and humans. The time-dependent
serum immune response to these common reactive antigens in humans is
similar to that in gerbils. O'Toole et al. (28) isolated
a 26-kDa species-specific protein that was shown to be antigenically
unique to H. pylori. It is interesting that Wang et al.
(37) reported that the 26-kDa protein, which was the same
one reported by O'Toole et al. (28) was associated with
gastric adenocarcinoma in humans.
From weeks 26 through 52 postinoculation, 5 of 24 gerbils (21%)
developed peptic ulcers, while others did not develop serious disease.
The remarkable feature of the host serum immune response of the ulcer
group was significantly higher anti-H. pylori IgG levels
than those of the hyperplastic group (P = 0.001). A
tendency for a higher proportion of animals to develop antibody to
H. pylori proteins of 26, 25, and 20 kDa as well as higher
antibody titers against 110- or 120-kDa proteins in the ulcer group
than in the hyperplastic group was also observed. The critical factors,
either host, bacterial, or environmental, that influence the
clinical manifestation of H. pylori infection are still
being elucidated. This study focused on host factors, since all animals
were infected with the same strain (ATCC 43504) of H. pylori. This strain is CagA and VacA positive and under the same
experimental conditions, designed to control for bacterial and
environmental factors, the animals had different outcomes. In addition,
the different outcomes (ulcer versus hyperplastic polyps) were
associated with different humoral immune responses, highlighting the
importance of the immune response of the host in the development of
H. pylori-related gastric lesions. The infection is not
cleared by the humoral immune response, and the mechanisms and
contribution of the activation of TH2 in the gerbil immune network must
be studied. The 110- and 120-kDa proteins have been identified as CagA
(33, 40), and the presence of anti-CagA has been
associated with an increased risk of developing ulcers and gastric
cancer (35). The gerbil model thus offers the opportunity
to examine the outcome of H. pylori infection both from the
perspective of the host and by altering the virulence of the infecting
strain (e.g., by selective knock out of putative virulence genes such
as cagA).
Although infection persisted in all gerbils, the number of animals with
ulcers appeared to decrease over time with 2 of 5 (40%), 1 of 4 (25%), and 2 of 13 (13%) gerbils exhibiting ulcers at 26, 38, and 52 weeks postinoculation, respectively. Watanabe et al. (38)
also reported the same tendency. Watanabe et al. used a gerbil model
infected with the H. pylori TN2GF4 strain, which was
isolated from a patient with gastric ulcer, and they found that 100, 100, 40, and 59% of the gerbils had ulcers at 26, 39, 52, and 62 weeks
postinoculation, respectively. The apparent drop in the prevalence of
ulcers could represent spontaneous healing of ulcers or
progressive damage to the gastric mucosa such that the animals were
unable to make sufficient acid to maintain the ulcers.
Clarification of antigens which are found to be involved in
H. pylori infection in the gerbil model used in this
study will promote our understanding of the mechanisms of H. pylori infection in gastric mucosa and the pathogenesis of
H. pylori-related disease in gastric mucosa.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Central Clinical
Laboratories, Shinshu University Hospital, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan. Phone: 81-263-35-4600 (ext. 5337). Fax: 81-263-34-5316. E-mail:
hota{at}hsp.md.shinshu-u.ac.jp.
 |
REFERENCES |
| 1.
|
Amersham Life Science Company.
1995.
ECM Western blotting protocols.
Amersham International PLC, Buckinghamshire, England.
|
| 2.
|
Aucher, P.,
M. L. Petit,
P. R. Mannant,
L. Pezennec,
P. Babin, and J. L. Fauchere.
1998.
Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers.
J. Clin. Microbiol.
36:931-936[Abstract/Free Full Text].
|
| 3.
|
Bode, G.,
P. Malfertheiner,
G. Lehnhardt,
M. Nilius, and H. Ditschuneit.
1993.
Ultrastructural localization of urease of Helicobacter pylori.
Med. Microbiol. Immunol.
182:233-242[CrossRef][Medline].
|
| 4.
|
Bolin, I.,
H. Lonroth, and A. M. Svennerholm.
1995.
Identification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein.
J. Clin. Microbiol.
33:381-384[Abstract].
|
| 5.
|
Bona, C. A., and F. A. Bonilla.
1996.
B cells and humoral immunity, p. 101-138.
In
C. A. Bona (ed.), Textbook of immunology, 2nd ed. Harwood Academic Publishers, Amsterdam, The Netherlands.
|
| 6.
|
Doig, P., and T. J. Trust.
1994.
Identification of surface-exposed outer membrane antigens of Helicobacter pylori.
Infect. Immun.
62:4526-4533[Abstract/Free Full Text].
|
| 7.
|
Drouet, E. B.,
G. A. Denoyel,
M. Boude,
E. Wallano,
M. Andujar, and H. P. DeMontclos.
1991.
Characterization of an immunoreactive species-specific 19-kilodalton outer membrane protein from Helicobacter pylori by using a monoclonal antibody.
J. Clin. Microbiol.
29:1620-1624[Abstract/Free Full Text].
|
| 8.
|
Dunn, B. E.,
G. I. Perez-Perez, and M. J. Blaser.
1989.
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins.
Infect. Immun.
57:1825-1833[Abstract/Free Full Text].
|
| 9.
|
Dunn, B. E.,
N. B. Vakil,
B. G. Schneider,
M. M. Miller,
J. B. Zitzer,
T. Peutz, and S. H. Phadnis.
1997.
Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies.
Infect. Immun.
65:1181-1188[Abstract].
|
| 10.
|
Evans, D. G.,
D. J. Evans, Jr.,
J. J. Moulds, and D. Y. Graham.
1988.
N-Acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen.
Infect. Immun.
56:2896-2906[Abstract/Free Full Text].
|
| 11.
|
Evans, D. G.,
T. K. Karjalainen,
D. J. Evans, Jr.,
D. Y. Graham, and C. H. Lee.
1993.
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori.
J. Bacteriol.
175:674-683[Abstract/Free Full Text].
|
| 12.
|
Evans, D. J., Jr.,
D. G. Evans,
S. S. Kirkpatrick, and D. Y. Graham.
1991.
Characterization of the Helicobacter pylori urease and purification of its subunits.
Microb. Pathog.
10:15-26[CrossRef][Medline].
|
| 13.
|
Evans, D. J., Jr.,
D. G. Evans,
T. Takamura,
H. Nakano,
C. L. Heather,
D. Y. Graham,
D. N. Granger, and P. R. Kvietys.
1995.
Characterization of a Helicobacter pylori neutrophil-activating protein.
Infect. Immun.
63:2213-2220[Abstract].
|
| 14.
|
Ey, P. L.,
S. J. Prowse, and C. R. Jenkin.
1978.
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.
Immunochemistry
15:429-436[CrossRef][Medline].
|
| 15.
|
Hawtin, P. R.,
A. R. Stacey, and D. G. Newell.
1990.
Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies.
J. Gen. Microbiol.
136:1995-2000[Medline].
|
| 16.
|
Herbert, B. R.,
M. P. Molloy,
A. A. Gooley,
B. J. Walsh,
W. G. Bryson, and K. L. Williams.
1998.
Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent.
Electrophoresis
19:845-851[CrossRef][Medline].
|
| 17.
|
Hirayama, F.,
S. Takagi,
H. Kusuhara,
E. Iwao,
Y. Yokoyama, and Y. Ikeda.
1996.
Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori.
J. Gastroenterol.
31:755-757[CrossRef][Medline].
|
| 18.
|
Hirayama, F.,
S. Takagi,
Y. Yokoyama,
E. Iwao, and Y. Ikeda.
1996.
Establishment of gastric Helicobacter pylori infection in Mongolian gerbils.
J. Gastroenterol.
31:24-28.
|
| 19.
|
Honda, S.,
T. Fujioka,
M. Tokieda,
R. Satoh,
A. Nishizone, and M. Nasu.
1998.
Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.
Cancer Res.
58:4255-4259[Abstract/Free Full Text].
|
| 20.
|
Ikeno, T.,
H. Ota,
A. Sugiyama,
K. Ishida,
T. Katsuyama,
R. M. Genta, and S. Kawasaki.
1999.
Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils.
Am. J. Pathol.
154:951-960[Abstract/Free Full Text].
|
| 21.
|
International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans.
1994.
Helicobacter pylori, p. 177-240.
In
Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of an IARC Working Group on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon, France.
|
| 22.
|
Ishikawa, E.,
M. Imagawa,
S. Hashida,
S. Yoshitake,
Y. Hamaguchi, and T. Ueno.
1983.
Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining.
J. Immunoassay
4:209-327[Medline].
|
| 23.
|
Kumagai, T.,
H. M. Malaty,
D. Y. Graham,
S. Hosogaya,
K. Misawa,
K. Furihata,
H. Ota,
C. Sei,
E. Tanaka,
T. Akamatsu,
T. Shimizu,
K. Kiyosawa, and T. Katsuyama.
1998.
Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study.
J. Infect. Dis.
178:717-721[Medline].
|
| 24.
|
Misawa, K.,
T. Kumagai,
T. Shimizu,
K. Furihata,
H. Ota,
T. Akamatsu, and T. Katsuyama.
1998.
A new histological procedure for re-evaluation of the serological test for Helicobacter pylori.
Eur. J. Clin. Microbiol. Infect. Dis.
17:14-19[CrossRef][Medline].
|
| 25.
|
Mitchell, H. M.,
S. L. Hazell,
Y. Y. Li, and P. J. Hu.
1996.
Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
Am. J. Gastroenterol.
92:1785-1788.
|
| 26.
|
Newell, D. G.
1987.
Human serum antibody responses to the surface protein antigens of Campylobacter pyloridis.
Serodiagn. Immunother.
1:209-217.
|
| 27.
|
Nilsson, I.,
Å. Ljungh,
P. Aleljung, and T. Wadstrom.
1997.
Immunoblot assay for serodiagnosis of Helicobacter pylori infection.
J. Clin. Microbiol.
35:427-432[Abstract].
|
| 28.
|
O'Toole, P. W.,
S. M. Logan,
M. Kostrzynska,
T. Wadstrom, and T. J. Trust.
1991.
Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori.
J. Bacteriol.
173:505-513[Abstract/Free Full Text].
|
| 29.
|
Ouchterlony, O.
1948.
In vitro method for testing the toxin-producing capacity of diphtheria bacteria.
Acta Pathol. Microbiol. Scand.
25:186-191[Medline].
|
| 30.
|
Sugiyama, A.,
F. Maruta,
T. Ikeno,
K. Ishida,
S. Kawasaki,
T. Katsuyama,
N. Shimizu, and M. Tatematsu.
1998.
Helicobacter pylori infection enhances N-methyl N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil.
Cancer Res.
58:2067-2069[Abstract/Free Full Text].
|
| 31.
|
Sugiyama, T.,
K. Imai,
H. Yoshida,
Y. Takayama,
T. Yabana,
K. Yokota,
K. Oguma, and A. Tachi.
1991.
A novel enzyme immunoassay for serodiagnosis of Helicobacter pylori infection.
Gastroenterology
101:77-83[Medline].
|
| 32.
|
Takahashi, I.,
J. R. McGhee,
S. Hamada, and H. Kiyono.
1997.
Oral immunization approaches for the prevention of gastrointestinal infections, p. 237-254.
In
P. B. Ernst, P. Michetti, and P. D. Smith (ed.), The immunobiology of H. pylori: from pathogenesis to prevention. Lippincott-Raven, Philadelphia, Pa.
|
| 33.
|
Telford, J.,
L. P. Ghiara,
M. Dell'Orco,
M. Commanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci,
Z. Xiang,
E. Papini,
C. Montecucco,
L. Parente, and R. Rappuoli.
1994.
Gene structure of Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658[Abstract/Free Full Text].
|
| 34.
|
Valkonen, K. H.,
T. Wadström, and A. P. Moran.
1997.
Identification of the N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori.
Infect. Immun.
65:916-923[Abstract].
|
| 35.
|
Van Doorn, L.-J.,
C. Figueiredo,
R. Sanna,
A. Plaisier,
P. Schneeberger,
W. Boer, and W. Quint.
1998.
Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.
Gastroenterology
115:58-66[CrossRef][Medline].
|
| 36.
|
Vos, J. G.,
J. Buys,
P. Beekhof, and A. M. Hagenaars.
1979.
Quantification of total IgM and IgG and specific IgM and IgG to a thymus-independent (LPS) and a thymus-dependent (tetanus toxoid) antigen in the rat by enzyme-linked immunosorbent assay (ELISA).
Ann. N. Y. Acad. Sci.
320:518-534[CrossRef][Medline].
|
| 37.
|
Wang, J. T.,
C. S. Chang,
C. Z. Lee,
J. C. Yang,
J. T. Lin, and T. H. Wang.
1998.
Antibody to a Helicobacter pylori species specific antigen in patient with adenocarcinoma of the stomach.
Biochem. Biophys. Res. Commun.
244:360-363[CrossRef][Medline].
|
| 38.
|
Watanabe, T.,
M. Tada,
H. Nagai,
S. Sasaki, and M. Nakao.
1998.
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils.
Gastroenterology
115:642-648[CrossRef][Medline].
|
| 39.
|
Whitehead, T. P.,
L. J. Kricka,
T. J. Carter, and G. H. Thorpe.
1979.
Analytical luminescence: its potential in the clinical laboratory.
Clin. Chem.
25:1531-1546[Abstract/Free Full Text].
|
| 40.
|
Xiang, Z.,
S. Censini,
P. F. Bayeli,
J. T. Telford,
N. Figura,
R. Rappuoli, and A. Covacci.
1995.
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.
Infect. Immun.
63:94-98[Abstract].
|
Journal of Clinical Microbiology, April 2001, p. 1283-1288, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1283-1288.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nurgalieva, Z. Z., Conner, M. E., Opekun, A. R., Zheng, C. Q., Elliott, S. N., Ernst, P. B., Osato, M., Estes, M. K., Graham, D. Y.
(2005). B-Cell and T-Cell Immune Responses to Experimental Helicobacter pylori Infection in Humans. Infect. Immun.
73: 2999-3006
[Abstract]
[Full Text]
-
Saito, H, Yamaoka, Y, Ishizone, S, Maruta, F, Sugiyama, A, Graham, D Y, Yamauchi, K, Ota, H, Miyagawa, S
(2005). Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model. Gut
54: 584-590
[Abstract]
[Full Text]
-
Yamaoka, Y., Yamauchi, K., Ota, H., Sugiyama, A., Ishizone, S., Graham, D. Y., Maruta, F., Murakami, M., Katsuyama, T.
(2005). Natural History of Gastric Mucosal Cytokine Expression in Helicobacter pylori Gastritis in Mongolian Gerbils. Infect. Immun.
73: 2205-2212
[Abstract]
[Full Text]
-
Nakagawa, S., Osaki, T., Fujioka, Y., Yamaguchi, H., Kamiya, S.
(2005). Long-Term Infection of Mongolian Gerbils with Helicobacter pylori: Microbiological, Histopathological, and Serological Analyses. CVI
12: 347-353
[Abstract]
[Full Text]
-
Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J.
(2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun.
70: 5096-5106
[Abstract]
[Full Text]